Stock doesn’t act right. Staying small and using a $38.50 stop. The catalyst presumably will be when sellside tells the story of patient out of pocket cost after first month free no co pay, to size the quickness of the uptake.
Rob’s Educated Guesses
Stock doesn’t act right. Staying small and using a $38.50 stop. The catalyst presumably will be when sellside tells the story of patient out of pocket cost after first month free no co pay, to size the quickness of the uptake.
Rob’s Educated Guesses